Trubion Pharmaceuticals

Antibody therapeutics and glycan biology research for precision medicine

placeSeattle, Washington, United States calendar_todayFounded 1999 language trubion.com

Innovation

35 patent families (7 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace dormant. Cited 2,884 times.

YearFilings
20122
20133
20152
20161
20172
20191

Investor mix

6 investors on record; lead investors include Prospect Venture Partners, Venrock; 1 has since exited.

Investor typeCountShare
Venture capital467%
Private equity117%
Other / undisclosed117%
Coming soon